» Articles » PMID: 1763890

Cerebral Amyloid Angiopathy Without and with Cerebral Hemorrhages: a Comparative Histological Study

Overview
Journal Ann Neurol
Specialty Neurology
Date 1991 Nov 11
PMID 1763890
Citations 209
Authors
Affiliations
Soon will be listed here.
Abstract

To identify those factors associated with cerebral hemorrhage among brains with cerebral amyloid angiopathy (CAA), we undertook a comparative postmortem histopathological study of amyloid-containing vessels in the brains of patients with and without hemorrhage. Those without hemorrhage were represented by the following two groups: (1) elderly patients from a large general hospital (n = 66; age range, 75-107 years) and (2) patients with various neuropsychiatric disorders (n = 70; age range, 27-96 years). CAA was found in 45% of the first group and in 54% of the second group. The findings in these patients were compared with those in 17 brains in which both CAA and cerebral hemorrhage were present. We found that CAA was more severe in the brains with cerebral hemorrhage than in those without, and that fibrinoid necrosis was seen only in the brains with cerebral hemorrhage (12 of the 17 brains). Microaneurysms occurred only in the presence of severe, rather than moderate or mild, CAA. Serial sections in 2 brains of patients with cerebral hemorrhage showed fibrinoid necrosis, microaneurysms, and vascular rupture in close association with the hemorrhage. In 2 patients, hemorrhage was precipitated by trauma, and in 1, it was secondary to metastatic carcinoma. The features of brains from patients with CAA that are most consistently related to cerebral hemorrhage are (1) a severe degree of CAA and (2) the presence of fibrinoid necrosis, with or without microaneurysms.

Citing Articles

Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer's disease.

Nehra G, Maloney B, Smith R, Chumboatong W, Abner E, Nelson P Fluids Barriers CNS. 2025; 22(1):4.

PMID: 39789614 PMC: 11720585. DOI: 10.1186/s12987-024-00615-8.


Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons.

Hu H, Wan S, Hu Y, Wang Q, Li H, Zhang N Ann Med. 2025; 57(1):2445194.

PMID: 39745195 PMC: 11703089. DOI: 10.1080/07853890.2024.2445194.


Amygdala-predominant α-synuclein pathology is associated with exacerbated hippocampal neuron loss in Alzheimer's disease.

Gawor K, Tome S, Vandenberghe R, Van Damme P, Vandenbulcke M, Otto M Brain Commun. 2024; 6(6):fcae442.

PMID: 39659977 PMC: 11631359. DOI: 10.1093/braincomms/fcae442.


Cerebral hypoperfusion reduces tau accumulation.

Gheni G, Shinohara M, Masuda-Suzukake M, Shindo A, Watanabe A, Kawai K Ann Clin Transl Neurol. 2024; 12(1):69-85.

PMID: 39621511 PMC: 11752094. DOI: 10.1002/acn3.52247.


Cerebral amyloid angiopathy impacts neurofibrillary tangle burden and cognition.

Godrich D, Pasteris J, Martin E, Rundek T, Schellenberg G, Foroud T Brain Commun. 2024; 6(6):fcae369.

PMID: 39584156 PMC: 11581998. DOI: 10.1093/braincomms/fcae369.